In part, the disclosure relates to a safety monitor and related methods to evaluate and manage intrapartum uterine contractions induced or augmented by Pitocin or other contraction inducing agents. The systems and methods include measuring a contraction parameter that may include one or more of frequency, strength, and duration of uterine contractions through a measurement device connected to a monitor. The systems and methods are programmed to stop the pump-based administration of a contraction inducing agent. Various lock out protocols and control over the ability to re-start a given pump are also described herein.

A medical device (e.g., an analyte sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The medical device may include a polymer covering at least a portion of a surface of the medical device and a plurality of reactive oxygen species (ROS) scavenger molecules covalently linked to the polymer (e.g., to reduce degradation of an analyte indicator including the polymer).

A glucose monitoring system includes a sensor control device comprising an analyte sensor coupled with sensor electronics, the sensor control device configured to transmit data indicative of an analyte level, and a reader device comprising a wireless communication circuitry configured to receive the data indicative of the analyte level, and one or more processors coupled with a memory. The memory is configured to store instructions that, when executed by the one or more processors, cause the one or more processors to: determine a frequency of interaction over a first time period based on one or more instances of user operation of the reader device, and output a first notification if the determined frequency of interaction is below a predetermined target level of interaction and output a second notification if the determined frequency of interaction is above the predetermined target level of interaction, wherein below the predetermined target level of interaction, an increase in the determined frequency of interaction corresponds to a first improvement in a metabolic parameter, and above the predetermined target level of interaction, an increase in the determined frequency of interaction corresponds to a second improvement in the metabolic parameter.

A medical instrument includes a shaft, one or more position sensors, a connector and interrogation circuitry. The shaft is configured for insertion into a body of a patient. The one or more position sensors are fitted at a distal end of the shaft. The connector is configured to receive a mating connector. The interrogation circuitry is configured to detect whether the mating connector is connected to the connector, and, if not connected, to prevent tracking a position of the distal end in the body using the one or more position sensors.

A continuous glucose monitoring (CGM) system is configured to detect a reinserted CGM sensor. The system reads a CGM sensor identifier stored in a CGM sensor unit memory in response to insertion of a CGM sensor into the skin of user. The system compares the identifier to any previously-stored identifiers of previously-inserted CGM sensors. If the identifier does not match a previously-stored identifier, indicating a newly-inserted sensor, the identifier is stored and CGM may begin. If the identifier matches a previously-stored identifier, indicating a reinserted sensor, a usage limit corresponding to the stored identifier of the reinserted sensor is then checked to determine whether it has been met. If it has, CGM is halted. If it has not, CGM may continue with the reinserted CGM sensor. Methods of detecting reinsertion and usage limits of a CGM sensor are also provided, as are other aspects.

An electrode patch for use with an external medical device, the electrode patch comprising: a first surface configured to be attached to a skin of a patient monitored by the external medical device, and an indicating mechanism disposed on the electrode patch and configured to indicate an end of a predetermined lifespan of the electrode patch.

Devices and methods for tissue and graft procedures are provided that are designed to fail under a certain amount of force, providing sensory feedback that a particular activity may be providing too much stress on a surgical implant. For example, a surgical implant can include a sacrificial element in the form of a filament designed to break when a certain threshold value of force is met or exceeded, while a second filament that has the ability to withstand higher values of force, is able to maintain the repair after the first filament fails. In other embodiments, the sacrificial element includes a filament engagement mechanism associated with a suture anchor configured to fail at a threshold value of force, and a second filament engagement mechanism of the anchor can maintain the repair after the first one fails. Many implants configurations are provided, as are various surgical methods incorporating sacrificial elements.

A medical instrument display includes an image storage that stores a plurality of image data of a medical instrument, a data analyzer that searches a plurality of image data stored in the image storage on a certain condition, and a display controller that causes a display to display a first medical instrument image that has been selected from thumbnail images, the thumbnail images being based on a plurality of the image data obtained by the search, and a second medical instrument image in good order, the second medical instrument image being different from the first medical instrument image.

A sleep medication dispensing system is for controlling release of a sleep medicament to a user based on sleep information related to the user. The system includes an electronic medicament dispensing device with a release mechanism to permit release of a controlled dose of a sleep medication which is stored in a holding area of the device. The system includes a processing arrangement which receives the user sleep pattern information, 5 and performs a release assessment which depends at least in part on the sleep pattern information. Release of a dose of the sleep medication in a given instance is made dependent upon an outcome of the release assessment. 10

A surgical gown tracking system is used for tracking a surgical gown. The surgical gown tracking system includes a chip and a chip reader. The chip is located on the surgical gown, and the chip is used for recording a usage record of the surgical gown and managing inventory. The chip reader is electrically connected to the chip and used for reading the usage record of the surgical gown.